Sep 8, 2026 06:09AM

Sep 8, 2026 05:27AM

Sep 4, 2026 04:52PM

Sep 1, 2026 06:04AM

Jul 31, 2026 04:31PM

Jul 22, 2026 02:48AM

Jul 21, 2026 07:29AM Novartis CEO says will stay with drugmaker for next growth phase

Jul 21, 2026 03:25AM

Jul 2, 2026 06:07AM

Jul 1, 2026 10:39AM

Jun 24, 2026 08:15AM

Jun 15, 2026 06:08AM

Jun 12, 2026 05:49AM

Jun 11, 2026 03:18AM Novartis reports positive biomarker results for experimental FSHD treatment

Jun 8, 2026 03:02AM

Jun 4, 2026 06:16AM

Jun 1, 2026 07:17AM

May 22, 2026 09:54AM

May 22, 2026 09:25AM

May 7, 2026 09:01AM

May 1, 2026 02:02PM Novartis receives Health Canada approval for Fabhalta® oral treatment for adults with C3G

Apr 30, 2026 07:04AM

Apr 30, 2026 07:01AM

Apr 24, 2026 06:31AM

Apr 9, 2026 03:55AM

Mar 30, 2026 04:18AM

Mar 27, 2026 04:03AM

Mar 23, 2026 04:52AM Novartis to present immunology data at dermatology meeting

Mar 20, 2026 08:21AM

Mar 16, 2026 12:54PM

Mar 13, 2026 01:37PM

Mar 11, 2026 07:34AM

Mar 11, 2026 04:37AM

Mar 6, 2026 08:35AM

Feb 27, 2026 06:44AM Novartis receives positive European opinion for CSU treatment remibrutinib

Feb 18, 2026 06:19AM

Feb 17, 2026 09:37AM

Jan 20, 2026 07:34AM

Jan 16, 2026 12:01PM

Jan 13, 2026 03:07PM

Jan 6, 2026 01:37PM

Dec 31, 2025 06:01AM Drugmakers Raise Us Prices On 350 Medicines Despite Pressure From Trump - Reuters

Dec 19, 2025 02:32PM

Dec 19, 2025 02:24PM

Dec 19, 2025 02:21PM

Dec 19, 2025 08:51AM

Dec 17, 2025 09:00AM

Dec 12, 2025 07:03AM

Dec 9, 2025 07:33AM Novartis reports positive Phase III results for ITP treatment combo

Dec 9, 2025 07:16AM

458,922 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All